How I approach diseaseâmodifying therapy in children with sickle cell disease in an era of novel therapies
Crossref DOI link: https://doi.org/10.1002/pbc.29363
Published Online: 2021-09-22
Published Print: 2021-12
Update policy: https://doi.org/10.1002/crossmark_policy
Karkoska, Kristine https://orcid.org/0000-0002-0990-399X
McGann, Patrick T. https://orcid.org/0000-0001-6198-4785
Version of Record valid from 2021-09-22
Publication History
Received: 2021-05-11
Accepted: 2021-09-06
Published: 2021-09-22
